5-Amino-1MQ vs MOTS-C

5-Amino-1MQ

5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that methylates nicotinamide and depletes the cellular pool of S-adenosyl methionine (SAM), a critical methyl donor. By inhibiting NNMT, 5-Amino-1MQ is proposed to increase intracellular NAD+ levels and SAM availability, thereby enhancing cellular energy metabolism and epigenetic regulation. Research published by Neelakantan et al. The same research group at the University of Texas showed that NNMT expression is upregulated in visceral adipose tissue of obese subjects, suggesting the enzyme plays a direct role in metabolic dysfunction. Unlike GLP-1 receptor agonists that suppress appetite centrally, 5-Amino-1MQ operates at the cellular metabolic level by modulating the NAD+ salvage pathway and methylation balance, offering a mechanistically distinct approach. Compared to NMN or NR supplementation (NAD+ precursors), 5-Amino-1MQ addresses NAD+ depletion at the enzymatic level rather than through precursor loading. Studies also suggest NNMT inhibition may improve insulin sensitivity through modulated SIRT1 activity. Store lyophilized powder at -20C protected from moisture; reconstitute in sterile water. This compound is investigated by metabolic biochemistry laboratories, NAD+ biology researchers, and academic institutions studying the intersection of epigenetics and obesity.

MOTS-C

MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA type-c) is a 16-amino acid peptide encoded within the mitochondrial genome, specifically within the 12S rRNA gene. Its primary mechanism of action involves activation of the AMPK pathway, which regulates cellular energy homeostasis by promoting glucose uptake and fatty acid oxidation independent of insulin signaling. Research published by Lee et al. (Cell Metabolism, 2015) demonstrated that MOTS-c use in diet-induced obese mice significantly improved glucose tolerance and reduced fat accumulation without altering food intake. Subsequent studies from the same USC laboratory showed that MOTS-c levels decline with age in human plasma, and that exercise increases circulating MOTS-c levels, suggesting it functions as a mitochondrial-derived exercise mimetic. Unlike traditional metabolic peptides that target specific membrane receptors, MOTS-c is unique in that it translocates to the nucleus under metabolic stress to regulate nuclear gene expression, particularly genes involved in the methionine-folate cycle and de novo purine biosynthesis. Compared to other mitochondrial-derived peptides like humanin, MOTS-c appears more specifically involved in metabolic regulation rather than cytoprotection. The lyophilized peptide should be stored at -20C and protected from light; reconstitute with bacteriostatic water and store reconstituted solutions at 2-8C for up to 21 days. MOTS-c is primarily researched by aging biology laboratories, exercise physiology departments, and mitochondrial medicine research centers investigating metabolic signaling peptides.

Frequently Asked Questions